UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 86 filers reported holding UTAH MED PRODS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $459,000 | +63.3% | 5,346 | +70.9% | 0.00% | 0.0% |
| Q1 2022 | $281,000 | -31.1% | 3,128 | -35.4% | 0.00% | 0.0% |
| Q4 2020 | $408,000 | -63.7% | 4,840 | -65.6% | 0.00% | -50.0% |
| Q3 2020 | $1,124,000 | -10.2% | 14,074 | -0.4% | 0.00% | 0.0% |
| Q2 2020 | $1,252,000 | -7.3% | 14,132 | -1.6% | 0.00% | 0.0% |
| Q1 2020 | $1,350,000 | -11.1% | 14,357 | +2.0% | 0.00% | 0.0% |
| Q4 2019 | $1,519,000 | -11.1% | 14,076 | -21.0% | 0.00% | 0.0% |
| Q3 2019 | $1,708,000 | -1.0% | 17,818 | -1.2% | 0.00% | 0.0% |
| Q2 2019 | $1,726,000 | +0.5% | 18,038 | -7.3% | 0.00% | 0.0% |
| Q1 2019 | $1,717,000 | -6.4% | 19,454 | -11.9% | 0.00% | 0.0% |
| Q4 2018 | $1,834,000 | -33.7% | 22,071 | -24.8% | 0.00% | -33.3% |
| Q3 2018 | $2,765,000 | +1118.1% | 29,350 | +1322.0% | 0.00% | – |
| Q2 2018 | $227,000 | – | 2,064 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clean Yield Group | 49,094 | $3,535,000 | 1.48% |
| MORGAN DEMPSEY CAPITAL MANAGEMENT LLC | 27,464 | $1,988,000 | 0.72% |
| Ativo Capital Management LLC | 16,525 | $1,196,000 | 0.33% |
| Ancora Advisors LLC | 55,159 | $3,993,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 10,754 | $779,000 | 0.23% |
| Cardinal Capital Management | 9,180 | $665,000 | 0.22% |
| Acrospire Investment Management LLC | 1,919 | $139,000 | 0.13% |
| Penobscot Investment Management Company, Inc. | 4,000 | $290,000 | 0.09% |
| TFS CAPITAL LLC | 3,226 | $234,000 | 0.09% |
| WCM INVESTMENT MANAGEMENT, LLC | 81,912 | $5,930,000 | 0.09% |